Subtype
Thyroid Gland Neoplasm
CI-CAN-00001600Explore in graph →
Non-malignant189 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001600Explore in graph →
Clinical trials
891 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00970359 | Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 | completed | N/A | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01865838 | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | terminated | N/A | 19 | National Cancer Centre, SingaporeOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT00729157 | Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2017 | clinicaltrials |
| NCT01534897 | Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00118248 | Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Feb 15, 2017 | clinicaltrials |
| NCT01838642 | Ponatinib for Advanced Medullary Thyroid Cancer | terminated | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Feb 15, 2017 | clinicaltrials |
| NCT00358956 | A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer | completed | Phase 2 | 19 | Genzyme, a Sanofi CompanyINDUSTRY | 8 | Jan 30, 2017 | clinicaltrials |
| NCT00559949 | Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 2 | Jan 30, 2017 | clinicaltrials |
| NCT02418247 | Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer | unknown | Phase 2 / Phase 3 | 556 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 20, 2017 | clinicaltrials |
| NCT03006289 | Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer | unknown | — | 3,000 | Lin LiaoOTHER | 0 | Dec 30, 2016 | clinicaltrials |
| NCT01083550 | Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer | completed | Phase 2 / Phase 3 | 74 | University Health Network, TorontoOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02952612 | Active Surveillance of Papillary Thyroid Microcarcinoma | unknown | — | 300 | Dong Jun LimOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02953288 | Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules. | unknown | — | 3,000 | Shanghai 10th People's HospitalOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01830504 | A Multicenter Phase II Pilot Open Label(BKM120) | unknown | Phase 2 | 47 | Hospices Civils de LyonOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02323724 | APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. | completed | — | 25 | Corporacion Parc TauliOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02706743 | Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer | unknown | — | 300 | Southern Medical University, ChinaOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT01915485 | Radiolabeled Molecules for Medullary Thyroid Cancer | unknown | Phase 4 | 20 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01757470 | Vandetanib Risk Minimisation Effectiveness | completed | — | 12 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02515084 | Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma(THYRIRMTEP) | completed | Phase 2 | 37 | Centre Henri BecquerelOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02869620 | Institut Paoli Calmettes Thyroid Cancer Database | recruiting | — | 3,000 | Institut Paoli-CalmettesOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
| NCT01403324 | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer(DOSIMETA) | terminated | N/A | 4 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT01625520 | SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer | completed | Phase 2 | 19 | Federico II UniversityOTHER | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01137097 | Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC(LSLNB) | completed | Phase 2 / Phase 3 | 278 | Samsung Medical CenterOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT00795782 | Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma | completed | Phase 3 | 258 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT02724176 | Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer | completed | N/A | 140 | Peking University Cancer Hospital & InstituteOTHER | 0 | Mar 31, 2016 | clinicaltrials |
| NCT01792492 | The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study | completed | — | 50 | Boston Medical CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02211222 | An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer | approved for marketing | — | — | Eisai Inc.INDUSTRY | 1 | Mar 16, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01994200 | Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients(ITCA-ThyCa) | withdrawn | Phase 1 / Phase 2 | 0 | Jewish General HospitalOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02516774 | A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers(TAM-RT) | withdrawn | Phase 1 | 0 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02648399 | Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma | unknown | N/A | 300 | Fujian Medical UniversityOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02645786 | Thyrotropin Over-suppression and Heart | completed | — | 31 | Chuncheon Sacred Heart HospitalOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01413113 | Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery | completed | Phase 1 | 6 | University of WashingtonOTHER | 1 | Nov 5, 2015 | clinicaltrials |
| NCT01173289 | Study of External Beam Radiotherapy to Thyroid Carcinoma | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01907997 | Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy | completed | N/A | 90 | Yonsei UniversityOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT01153945 | Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum | withdrawn | — | 0 | Meir Medical CenterOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00400465 | Is the Routine Pressure Dressing After Thyroidectomy Necessary? | completed | Phase 4 | 116 | Khon Kaen UniversityOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT01292044 | The Role of Elastography in the Diagnosis of Thyroid Nodules | completed | N/A | 188 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT01736163 | A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours | completed | — | 144 | Genzyme, a Sanofi CompanyINDUSTRY | 4 | Mar 23, 2015 | clinicaltrials |
| NCT00196729 | Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration | completed | Phase 3 | 63 | Genzyme, a Sanofi CompanyINDUSTRY | 0 | Mar 18, 2015 | clinicaltrials |
| NCT01311089 | A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy | completed | — | 169 | Yonsei UniversityOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00598364 | Molecular Markers in Thyroid Cancer | completed | — | 847 | OHSU Knight Cancer InstituteOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01964144 | An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer | completed | Phase 2 | 40 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Apr 12, 2017source: clinicaltrials